CY1112821T1 - Ενωσεις για την επιλεκτικη θεραπεια της εντερικης ανοσο-φλεγμονωδους συνιστωσας της κοιλιοκακης - Google Patents

Ενωσεις για την επιλεκτικη θεραπεια της εντερικης ανοσο-φλεγμονωδους συνιστωσας της κοιλιοκακης

Info

Publication number
CY1112821T1
CY1112821T1 CY20121100511T CY121100511T CY1112821T1 CY 1112821 T1 CY1112821 T1 CY 1112821T1 CY 20121100511 T CY20121100511 T CY 20121100511T CY 121100511 T CY121100511 T CY 121100511T CY 1112821 T1 CY1112821 T1 CY 1112821T1
Authority
CY
Cyprus
Prior art keywords
treatment
compounds
covilla
optive
inflammatory composition
Prior art date
Application number
CY20121100511T
Other languages
English (en)
Inventor
Sergio Baroni
Salvatore Bellinvia
Original Assignee
Giuliani International Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Giuliani International Limited filed Critical Giuliani International Limited
Publication of CY1112821T1 publication Critical patent/CY1112821T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Σε μία πτυχή, η παρούσα εφεύρεση σχετίζει τις αμινο-σαλικυλικο-αμινοφαινυλοπροπιονικές ενώσεις για τη χρήση στη θεραπεία της φλεγμονώδους συνιστώσας της κοιλιοκάκης. Αυτές οι ενώσεις δρουν μέσω δέσμευσης των κυτταροκινών που απελευθερώνονται στην κοιλιοκάκη και είναι ειδικά χρήσιμες στη θεραπεία περιπτώσεων ανθεκτικών στη δίαιτα, σε διαιτητικά λάθη και στη μείωση του χρόνου ύφεσης της κοιλιοκάκης.
CY20121100511T 2007-12-24 2012-06-06 Ενωσεις για την επιλεκτικη θεραπεια της εντερικης ανοσο-φλεγμονωδους συνιστωσας της κοιλιοκακης CY1112821T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002429A ITMI20072429A1 (it) 2007-12-24 2007-12-24 Composti per il trattamento selettivo della componente immuno-infiammatoria intestinale della malattia celiaca
EP08863709A EP2222291B1 (en) 2007-12-24 2008-12-23 Compounds for the selective treatment of the intestinal immuno-inflammatory component of the celiac disease

Publications (1)

Publication Number Publication Date
CY1112821T1 true CY1112821T1 (el) 2016-02-10

Family

ID=40315657

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20121100511T CY1112821T1 (el) 2007-12-24 2012-06-06 Ενωσεις για την επιλεκτικη θεραπεια της εντερικης ανοσο-φλεγμονωδους συνιστωσας της κοιλιοκακης

Country Status (23)

Country Link
US (2) US8153693B2 (el)
EP (2) EP2279733A3 (el)
JP (1) JP2011507818A (el)
KR (1) KR20100103836A (el)
CN (2) CN101969943A (el)
AT (1) ATE550020T1 (el)
AU (1) AU2008339909A1 (el)
BR (1) BRPI0821331A2 (el)
CA (1) CA2708512A1 (el)
CY (1) CY1112821T1 (el)
DK (1) DK2222291T3 (el)
EA (1) EA201001058A1 (el)
ES (1) ES2384361T3 (el)
HR (1) HRP20120404T1 (el)
IL (1) IL206226A0 (el)
IT (1) ITMI20072429A1 (el)
MX (1) MX2010007033A (el)
NZ (1) NZ586191A (el)
PL (1) PL2222291T3 (el)
PT (1) PT2222291E (el)
SI (1) SI2222291T1 (el)
WO (1) WO2009080828A2 (el)
ZA (1) ZA201004802B (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
ITRM20050389A1 (it) 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
ITRM20050390A1 (it) 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
UA107562C2 (uk) 2008-12-05 2015-01-26 Спосіб лікування псоріазу
BRPI1008752B1 (pt) 2009-02-16 2020-02-11 Nogra Pharma Limited Compostos alquilamido, composições farmacêuticas e usos dos mesmos
CA2810283A1 (en) * 2010-09-10 2012-03-15 Pharmazell Gmbh Process for producing crystalline 5-aminosalicylic acid
JP6301844B2 (ja) 2012-02-09 2018-03-28 ノグラ ファーマ リミテッド 線維症の処置方法
KR20150002819A (ko) 2012-04-18 2015-01-07 노그라 파마 리미티드 락토스 불내증의 치료 방법
WO2019164874A1 (en) * 2018-02-20 2019-08-29 Western New England University Thiol isomerases inhibitors for the treatment and prevention of food allergies, allergic diseases, and inflammatory diseases
CN113825739A (zh) 2019-02-08 2021-12-21 诺格拉制药有限公司 制备3-(4’-氨基苯基)-2-甲氧基丙酸及其类似物和中间体的方法
CN113801126A (zh) * 2021-07-20 2021-12-17 云南大学 一种多取代吡啶衍生物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001285311B2 (en) * 2000-08-29 2005-09-15 Biocon, Ltd Immunoregulatory compounds, derivatives thereof and their use
WO2005072113A2 (en) 2004-01-20 2005-08-11 Harty Richard F Compositions and methods of treatment for inflammatory diseases
WO2006125293A1 (en) * 2005-05-27 2006-11-30 Antibe Therapeutics Inc. Derivatives of 4- or 5-aminosalicylic acid
US20060270635A1 (en) * 2005-05-27 2006-11-30 Wallace John L Derivatives of 4- or 5-aminosalicylic acid
ITRM20050389A1 (it) * 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
ITRM20050390A1 (it) * 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.

Also Published As

Publication number Publication date
EP2279733A3 (en) 2011-03-23
BRPI0821331A2 (pt) 2015-06-16
WO2009080828A2 (en) 2009-07-02
EA201001058A1 (ru) 2011-02-28
NZ586191A (en) 2012-06-29
EP2279733A2 (en) 2011-02-02
IL206226A0 (en) 2010-12-30
EP2222291A2 (en) 2010-09-01
CN102641279A (zh) 2012-08-22
AU2008339909A1 (en) 2009-07-02
WO2009080828A3 (en) 2009-10-01
CA2708512A1 (en) 2009-07-02
JP2011507818A (ja) 2011-03-10
ATE550020T1 (de) 2012-04-15
US20120157417A1 (en) 2012-06-21
PT2222291E (pt) 2012-07-02
CN101969943A (zh) 2011-02-09
EP2222291B1 (en) 2012-03-21
SI2222291T1 (sl) 2012-08-31
MX2010007033A (es) 2010-10-07
ES2384361T3 (es) 2012-07-04
US8153693B2 (en) 2012-04-10
PL2222291T3 (pl) 2012-08-31
ZA201004802B (en) 2011-03-30
HRP20120404T1 (hr) 2012-06-30
ITMI20072429A1 (it) 2009-06-25
DK2222291T3 (da) 2012-06-25
KR20100103836A (ko) 2010-09-28
US20100305077A1 (en) 2010-12-02

Similar Documents

Publication Publication Date Title
CY1112821T1 (el) Ενωσεις για την επιλεκτικη θεραπεια της εντερικης ανοσο-φλεγμονωδους συνιστωσας της κοιλιοκακης
MY159850A (en) Tetracyclic compounds
EA200701471A1 (ru) Замещённые пиридинильные и пиримидинильные производные, используемые в качестве модуляторов метаболизма и лечение ассоциированных с ним расстройств
EA200801897A1 (ru) Ингибиторы mnk2 на основе 8-гетероарилпурина для лечения метаболических нарушений
BRPI0820967A2 (pt) Uso de uma composição, composição farmacêutica e método para tratamento, melhora ou profilaxia dos sintomas de uma doença inflamatória
TW200610528A (en) Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
IL195030A (en) IV dpp inhibitor assemblies
EA201170052A1 (ru) Производные тиофена или тиазола и их применение как ингибиторов pi3k
EA200801428A1 (ru) Производные пиридиазинона для лечения опухолей
BRPI0911197A2 (pt) composto, ativador de receptor ativado pelo proliferador de peroxissoma, e, medicamento para o tratamento e /ou profilaxia de uma doença.
WO2009046842A3 (de) Thialzolderivate zur behandlung von krebs
PL2018184T3 (pl) Przeciwciało Anty-VEGF-B do stosowania w leczeniu lub profilaktyce cukrzycy typu II lub zespołu metabolicznego
MX2013004004A (es) Pirrolidinonas como inhibidores de metionina aminopeptidasa (metap-2).
DOP2010000062A (es) Derivados de ciclopropilamida
IL186217A0 (en) Anti-inflammatory modalities
MX2012012094A (es) Sintesis novedosa para compuestos de tiazolidinadiona.
BRPI0914940A8 (pt) Composições nutritivas contendo punicalaginas
BRPI0808823A2 (pt) composição e método para tratar, reduzir, melhorar ou prevenir uma infecção.
AP2008004613A0 (en) Novel use of antihistamine agents for the preventative or early treatment of inflammatory syndromes,in particular those triggered by togaviruses
MX2012012092A (es) Sintesis novedosa para compuestos de tiazolidinadiona.
DK2231633T3 (da) Antitumorale forbindelser
BRPI0811557A2 (pt) composto, composição farmacêutica, método de tratamento ou profilaxia de uma condição inflamatória.
MX2013001475A (es) Sintesis para compuestos de tiazolidindiona.
MX2009007852A (es) Sulfonamidas sustituidas con heterociclilos para el tratamiento de trastornos cognitivos o relacionados con ingestion de alimentos.
MX349006B (es) Nueva sintesis para compuestos de tiazolidindiona.